Journal of Clinical Oncology, ASCO Annual Meeting Proceedings (Post-Meeting Edition).
Vol , No 15S ( Supplement), :
© 2009 American Society of Clinical Oncology

Return to article

Changes in BMD from Baseline

Measurement (g/cm) Risedronate Placebo P Value L Total - change at 1 year –0.06 –0.07 0.324 Femoral neck - change at 1 year –0.03 –0.03 0.364 Total hip - change at 1 year –0.03 –0.04 0.453

Return to article